Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin.
Viral N ShahEdward FranekKarin Wernicke-PantenSuzanne PierreBhaswati MukherjeeKarita SadeharjuPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
ClinicalTrials.gov identifier: NCT03211858.